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The Czech Society of Cardiology is proposing here the new classiﬁcation of acute coronary
syndromes at the time of the ﬁrst medical contact. The proposal suggests to remove the
terms “ST elevation myocardial infarction” and “non-ST elevation acute coronary syn-
drome” and to replace these terms by “acute coronary syndrome with ongoing myocardial
ischemia” and “acute coronary syndrome without ongoing myocardial ischemia”. The
proposed new classiﬁcation better reﬂects current treatment approaches and will facilitate
the decision making at the ﬁrst medical contact.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Fig. 1 – Scheme of the old (A) and the proposed new (B)
classiﬁcation of acute coronary syndromes.
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The current classiﬁcation of acute coronary syndromes in two
main categories (acute myocardial infarction with ST seg-
ment elevation—STEMI and acute coronary syndromes with-
out ST segment elevation—non-STE ACS) is historically based
on the need to deﬁne patients indicated for thrombolytic
therapy. Thrombolytic therapy was shown to be effective in
STEMI, while it is ineffective in non-STE ACS [1,2]. However,
thrombolytic therapy for STEMI is currently replaced by a
more effective therapy – primary percutaneous coronary
intervention (p-PCI) – in most European countries and also
increasingly worldwide [3,4]. In contrast to thrombolysis,
acute PCI is useful in a broader spectrum of acute coronary
syndromes. Thus, the ﬁrst line decision dilemma today is not
anymore “whether to use thrombolysis” (this decision was
based on the presence or absence of ST segment elevations)
but rather “whether to send the patient directly to cath-lab”. This
decision should not be based on ST elevations but rather on
the signs of ongoing ischemia or hemodynamic instability
with any ECG pattern.
According to the recent ESC guidelines [5,6] an emergent
invasive (p-PCI like) strategy is indicated not only for STEMI, but
also for the highest risk subgroups of patients with non-STE
ACS. Furthermore, many patients with critical (life-threatening)
angiographic ﬁndings do not present with ST segment eleva-
tions (left main coronary artery critical lesions, left circumﬂex
occlusion etc.), while these patients (as well as many others
with ongoing acute myocardial infarction without ST eleva-
tions) clearly beneﬁt from an emergent coronary angiography
(CAG) and PCI [7]. Deliberate delaying of coronary angiography
due to the absence of ST segment elevations in these critical
situations may cause deterioration in clinical status (including
unnecessary deaths) in real life practice.
Thus, the Czech Society of Cardiology decided to propose a
new classiﬁcation of acute coronary syndromes based on the
presence or absence of ongoing ischemia at the time of ﬁrst
medical contact or hospital emergency room presentation.
This classiﬁcation is focused on the initial presentation (with
the need to immediately decide whether to proceed to the
cathlab/primary PCI facility or not) and is not focused on the
ﬁnal diagnosis—thus it does not primarily take biomarkers
into the initial decision scheme. Some Czech tertiary centers
use this classiﬁcation already today in their treatment pro-
tocols [8] (Fig. 1).2. The proposed new classiﬁcation of acute
coronary syndromes (Fig. 1)
Acute coronary syndromes should be classiﬁed according to
the ﬁrst medical contact decision where to transport the
patient: (a) immediately (within o2 h from the ﬁrst medical
contact) to the catheterization laboratory of the nearest
PCI-capable hospital, or (b) to the nearest coronary care unit
(including hospitals without PCI facilities). In principle, the (a)
category includes all patients with ongoing (evolving or
recurrent) signs of acute myocardial ischemia with any ECG
pattern (ST elevations, ST depressions, bundle branch block,or even non-diagnostic ECG if the clinical suspicion is very
strong—e.g. in left circumﬂex artery occlusion) and also
patients with any form of acute coronary syndrome compli-
cated by hemodynamic or electric instability (Killip II–IV class
or malignant arrhythmias—of course only when combined with
clinical symptoms of possible acute coronary syndrome). The
(b) category includes all other forms of acute coronary syn-
dromes—i.e. situations when a delay of 24–72 h (with decision
about CAG/PCI) is unlikely to cause any risk for the patient.(a) Acute coronary syndrome with ongoing myocardial ische-
mia is deﬁned as ongoing (or recurrent) clinical signs of
acute myocardial ischemia (i.e. persistent chest pain and/or
dyspnea at rest) plus at least one of the following:
(1) ST segment elevations in ≥2 consecutive ECG leads
(≥2 mm for leads V2–V3, ≥0,5 mm for leads V7–V9 and
≥1 mm for other leads);
(2) new onset bundle branch block (right or left);
(3) persistent ST segment depressions in ≥2 consecutive
ECG leads (≥2 mm for chest leads and ≥1 mm for
extremity leads);
(4) cardiogenic shock or “pre-shock” type of hemodynamic
instability (low-to-normal blood pressure+tachycardia
+cool extremities) due to suspected ischemia;
(5) malignant arrhythmias including resuscitated cardiac
arrest with return of spontaneous circulation;
(6) clinical signs of acute heart failure (Killip II–IV); and
(7) new onset of a wall motion abnormality on cardiac
imaging.
It is important to keep in mind, that isolated ﬁndings
listed under 1–7 above (e.g. malignant arrhythmias
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not fulﬁll this deﬁnition. The high clinical suspicion for
acute myocardial infarction is important. Direct trans-
port to cathlab (bypassing any other location—e.g.
intensive care unit or emergency room) is always
required in groups 1–4. Patients from groups 5–7 should
also be transported to a non-stop (24/7) primary PCI
facility (either directly to cath-lab or they may be
primarily admitted to the intensive cardiac care unit
with cath-lab immediately available).(b) Acute coronary syndrome without ongoing myocardial ische-
mia includes all other acute coronary syndromes. Speci-
ﬁcally, these are the patients with unstable angina and
with small acute myocardial infarction (troponin eleva-
tion) not having the above mentioned signs of ongoing
ischemia at the time of ﬁrst medical contact.
The intended main value of this newly proposed classiﬁ-
cation is in the immediate decision making whether to
proceed directly to cath-lab (of a 24/7 PCI hospital) as an
emergency (“p-PCI like strategy”) or whether to postpone
coronary angiography for the next (working) day. This classi-
ﬁcation will have a real practical value for physicians of all
specialties coming into the ﬁrst medical contact with ACS
patients. The Czech Society of Cardiology presented partially
similar classiﬁcation already in its STEMI guidelines 2002 [9].
These 2002 guidelines considered ST depression acute myo-
cardial infarction as an emergency with analogous triage (i.e.
indication for immediate invasive assessment and therapy in
24/7 PCI facility) as STEMI.
The role of cardiac troponin remains very important for
the ﬁnal conﬁrmation of the diagnosis of acute myocardial
infarction. This classiﬁcation does not challenge the deﬁni-
tion of acute myocardial infarction. The goal is to provide
clear and simple practical guideline for the ﬁrst medical
contact decisions.Acknowledgment
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